One study showed that elevated serum C-reactive protein (CRP) levels were significantly associated with poor clinical outcomes in patients with PC (11), while another study found that the CRP-to-albumin ratio could be a significant and promising inflammatory prognostic score (12). This evidence concerns the gene CRP and pachyonychia congenita.